US Supreme Court to Deal with the Patent Enablement Standard
IPilogue
FEBRUARY 13, 2023
Specifically, Amgen seeks to appeal a decision from the Federal Circuit , in which the court found Amgen’s patents invalid for lack of enablement. The requirement of enablement in US patent law is codified in 35 USC s. In 2014, Amgen sued Sanofi for infringing on its patents concerning drugs for lowering cholesterol.
Let's personalize your content